EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Human Mesenchymal Stem Cell Derived Exosomes Endowed with miR-13474 as a Therapeutic Delivery Vehicle for Diabetic Wound Healing by Targeting the CPEB2/TWIST1 Axis

Hui Shi, Xinye Han, Yuting Lu, Yingzhe Li, Hanqiang Lu, Hui Qian iD, Wenrong Xu iD

ACS Applied Bio Materials · 2025

DOI: 10.1021/acsabm.5c01352 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Bio Materials, 2025. Verfasst von Hui Shi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, the Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu 212013, China. Hauptthemen laut MEDLINE: MicroRNAs, Exosomes, Wound Healing, Mesenchymal Stem Cells. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Jiangsu Province, National Natural Science Foundation of China, The Technology Development Project of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A delayed healing process in diabetic wounds is intractable. In this study, a high-glucose condition was found to be responsible for skin structure destruction, inflammatory infiltration, and vital cell dysfunction. Extracellular vesicles, particularly exosomes secreted by hucMSCs, contribute to improved diabetic wound healing, largely by promoting tissue repair and re-establishing normal function in affected cells. Small RNA-sequencing revealed that hucMSC-derived exosomes (hucMSC-Ex) were highly enriched in NC_000019.10_13474 (miR-13474), which was predicted to be an miRNA with an undiscovered function. miR-13474 showed a reduced expression level in high-glucose-treated skin cells as well as diabetic foot ulcer (DFU) rats. Moreover, there is also a significant expression difference between the wound area and the wound edge in DFU patients, indicating the potential clinical value of miR-13474. Blocking miR-13474 in hucMSC-Ex obviously diminished the therapeutic effects. Furthermore, exosomal miR-13474 was found to target the CPEB2/TWIST1 axis to improve the impaired function of skin cells. On this basis, hucMSC-Ex were used as a vehicle for the delivery of therapeutic miR-13474 to optimize the repairing effect. The study has revealed the role of hucMSC-derived exosomes and the underlying molecular mechanism in diabetic wound healing and proposes a cell-free-based modification strategy for refractory wound management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsExosomesWound HealingMesenchymal Stem CellsBiocompatible MaterialsRNA-Binding ProteinsNuclear ProteinsDiabetic FootHumansAnimalsRatsRats, Sprague-DawleyDiabetes Mellitus, ExperimentalMaleParticle Size

Stichwörter der Autor:innen

diabetic wound healingexosomesmiRNAssmall extracellular vesiclestherapy

Substanzen

MicroRNAsBiocompatible MaterialsRNA-Binding ProteinsNuclear Proteins

Autor:innen und Institutionen

  • Department of Otorhinolaryngology, the Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu 212013, China.
  • Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, Institute of Stem Cell, Department of Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, Jiangsu 212013, China.
  • Pharmaceutical Sciences Laboratory, Åbo Akademi University, Turku 20520, Finland.
  • Department of Blood Transfusion, the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China.
  • Department of laboratory medicine, Haian Hospital of Traditional Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nantong 226600, China.

ORCID-Profile: Hui Qian, Wenrong Xu

Förderung

  • Natural Science Foundation of Jiangsu Province
  • National Natural Science Foundation of China
  • The Technology Development Project of Jiangsu Province

Zitieren

APA

Shi, H., Han, X., Lu, Y., Li, Y., Lu, H., Qian, H., & Xu, W. (2025). Human Mesenchymal Stem Cell Derived Exosomes Endowed with miR-13474 as a Therapeutic Delivery Vehicle for Diabetic Wound Healing by Targeting the CPEB2/TWIST1 Axis. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.5c01352

Vancouver

Shi H, Han X, Lu Y, Li Y, Lu H, Qian H, et al. Human Mesenchymal Stem Cell Derived Exosomes Endowed with miR-13474 as a Therapeutic Delivery Vehicle for Diabetic Wound Healing by Targeting the CPEB2/TWIST1 Axis. ACS Applied Bio Materials. 2025. doi:10.1021/acsabm.5c01352

BibTeX
@article{Shi2025,
  author = {Shi, Hui and Han, Xinye and Lu, Yuting and Li, Yingzhe and Lu, Hanqiang and Qian, Hui and Xu, Wenrong},
  title = {Human Mesenchymal Stem Cell Derived Exosomes Endowed with miR-13474 as a Therapeutic Delivery Vehicle for Diabetic Wound Healing by Targeting the CPEB2/TWIST1 Axis},
  journal = {ACS Applied Bio Materials},
  year = {2025},
  doi = {10.1021/acsabm.5c01352}
}
Kostenlos starten →